Patients with aneurysmal subarachnoid haemorrhage treated in Swedish intensive care: A registry study.
intensive care
neuro intensive care
neurosurgery
registry
subarachnoid haemorrhage
Journal
Acta anaesthesiologica Scandinavica
ISSN: 1399-6576
Titre abrégé: Acta Anaesthesiol Scand
Pays: England
ID NLM: 0370270
Informations de publication
Date de publication:
29 May 2024
29 May 2024
Historique:
revised:
05
05
2024
received:
11
12
2023
accepted:
06
05
2024
medline:
30
5
2024
pubmed:
30
5
2024
entrez:
30
5
2024
Statut:
aheadofprint
Résumé
Aneurysmal subarachnoid haemorrhage (aSAH) is a life-threatening disease with high mortality and morbidity. Patients with aSAH in Sweden are cared for at one of six neuro intensive care units (NICU) or at a general intensive care unit (ICU).This study aimed to describe the incidence, length of stay, time in ventilator and mortality for these patients. This is a retrospective, descriptive study of patients with aSAH, registered in the Swedish Intensive care Registry between 2017 and 2019. The cohort was divided in sub-cohorts (NICU and general ICU) and regions. Mortality was analysed with logistic regression. A total of 1520 patients with aSAH from five regions were included in the study. Mean age of the patients were 60.6 years and 58% were female. Mortality within 180 days of admission was 30% (n = 456) of which 17% (n = 258) died during intensive care. A majority of the patients were treated at one hospital and in one ICU (70%, n = 1062). More than half of the patients (59%, n = 897) had their first intensive care admission at a hospital with a NICU. Patients in the North region had the lowest median GCS (10) and the highest SAPS3 score (60) when admitted to NICU. Treatment with invasive mechanical ventilation differed significantly between regions; 91% (n = 80) in the region with highest proportion versus 56% (n = 94) in the region with the lowest proportion, as did mortality; 16% (n = 44) versus 8% (n = 23). No differences between regions were found regarding age, sex and length of stay. Patients with aSAH treated in a NICU or in an ICU in Sweden differs in characteristics. The study further showed some differences between regions which might be reduced if there were national consensus and treatment guidelines implemented.
Sections du résumé
BACKGROUND
BACKGROUND
Aneurysmal subarachnoid haemorrhage (aSAH) is a life-threatening disease with high mortality and morbidity. Patients with aSAH in Sweden are cared for at one of six neuro intensive care units (NICU) or at a general intensive care unit (ICU).This study aimed to describe the incidence, length of stay, time in ventilator and mortality for these patients.
METHODS
METHODS
This is a retrospective, descriptive study of patients with aSAH, registered in the Swedish Intensive care Registry between 2017 and 2019. The cohort was divided in sub-cohorts (NICU and general ICU) and regions. Mortality was analysed with logistic regression.
RESULTS
RESULTS
A total of 1520 patients with aSAH from five regions were included in the study. Mean age of the patients were 60.6 years and 58% were female. Mortality within 180 days of admission was 30% (n = 456) of which 17% (n = 258) died during intensive care. A majority of the patients were treated at one hospital and in one ICU (70%, n = 1062). More than half of the patients (59%, n = 897) had their first intensive care admission at a hospital with a NICU. Patients in the North region had the lowest median GCS (10) and the highest SAPS3 score (60) when admitted to NICU. Treatment with invasive mechanical ventilation differed significantly between regions; 91% (n = 80) in the region with highest proportion versus 56% (n = 94) in the region with the lowest proportion, as did mortality; 16% (n = 44) versus 8% (n = 23). No differences between regions were found regarding age, sex and length of stay.
CONCLUSIONS
CONCLUSIONS
Patients with aSAH treated in a NICU or in an ICU in Sweden differs in characteristics. The study further showed some differences between regions which might be reduced if there were national consensus and treatment guidelines implemented.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.
Références
Al‐Khindi T, Macdonald RL, Schweizer TA. Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke. 2010;41(8):e519‐e536. (In eng). doi:10.1161/strokeaha.110.581975
Etminan N, Macdonald RL. Management of aneurysmal subarachnoid hemorrhage. Handb Clin Neurol. 2017;140:195‐228. (In eng). doi:10.1016/b978‐0‐444‐63600‐3.00012‐x
Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg. 2013;79(2):307‐312. (In eng). doi:10.1016/j.wneu.2012.06.023
Hoh BL, Ko NU, Amin‐Hanjani S, et al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2023;54(7):e314‐e370. (In eng). doi:10.1161/str.0000000000000436
Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44‐58. (In eng). doi:10.1038/nrneurol.2013.246
Macdonald RL, Schweizer TA. Spontaneous subarachnoid haemorrhage. Lancet. 2017;389(10069):655‐666. (In eng). doi:10.1016/s0140‐6736(16)30668‐7
Hop JW, Rinkel GJ, Algra A, van Gijn J. Case‐fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28(3):660‐664. (In eng). doi:10.1161/01.str.28.3.660
Rinkel GJ, Algra A. Long‐term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2011;10(4):349‐356. (In eng). doi:10.1016/s1474‐4422(11)70017‐5
Etminan N, Chang HS, Hackenberg K, et al. Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta‐analysis. JAMA Neurol. 2019;76(5):588‐597. (In eng). doi:10.1001/jamaneurol.2019.0006
Ikawa F, Morita A, Nakayama T, et al. A register‐based SAH study in Japan: high incidence rate and recent decline trend based on lifestyle. J Neurosurg. 2020;134(3):983‐991. (In eng). doi:10.3171/2020.1.Jns192848
Korja M, Lehto H, Juvela S, Kaprio J. Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates. Neurology. 2016;87(11):1118‐1123. (In eng). doi:10.1212/wnl.0000000000003091
Koffijberg H, Buskens E, Granath F, et al. Subarachnoid haemorrhage in Sweden 1987‐2002: regional incidence and case fatality rates. J Neurol Neurosurg Psychiatry. 2008;79(3):294‐299. (In eng). doi:10.1136/jnnp.2007.123901
Etminan N, Macdonald RL. Neurovascular disease, diagnosis, and therapy: subarachnoid hemorrhage and cerebral vasospasm. Handb Clin Neurol. 2021;176:135‐169. (In eng). doi:10.1016/b978‐0‐444‐64034‐5.00009‐2
Green DM, Burns JD, DeFusco CM. ICU management of aneurysmal subarachnoid hemorrhage. J Intensive Care Med. 2013;28(6):341‐354. (In eng). doi:10.1177/0885066611434100
Rabinstein AA, Lanzino G, Wijdicks EF. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2010;9(5):504‐519. (In eng). doi:10.1016/s1474‐4422(10)70087‐9
Cross DT 3rd, Tirschwell DL, Clark MA, et al. Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states. J Neurosurg. 2003;99(5):810‐817. (In eng). doi:10.3171/jns.2003.99.5.0810
Connolly ES Jr, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43(6):1711‐1737. (In eng). doi:10.1161/STR.0b013e3182587839
Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population‐based study and systematic review. Neurology. 2010;74(19):1494‐1501. (In eng). doi:10.1212/WNL.0b013e3181dd42b3
Top 25—Main ICU‐diagnoses. Swedish Intensive Care Registry. https://portal.icuregswe.org/utdata/en/report/prod_diagnoser-antal Accessed June 8, 2023.
Guideline for Swedish Intensive Care. Swedish Intensive Care Registry. https://portal.icuregswe.org/seiva/en/Rapport Accessed June 8, 2023.
Treggiari MM, Rabinstein AA, Busl KM, et al. Guidelines for the neurocritical Care Management of Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2023;39:1‐28 (In eng). doi:10.1007/s12028‐023‐01713‐5
Rozich JD, Howard RJ, Justeson JM, Macken PD, Lindsay ME, Resar RK. Standardization as a mechanism to improve safety in health care. Jt Comm J Qual Saf. 2004;30(1):5‐14. (In eng). doi:10.1016/s1549‐3741(04)30001‐8
Walther SM, Jonasson U, Gill H. Comparison of the Glasgow coma scale and the reaction level scale for assessment of cerebral responsiveness in the critically ill. Intensive Care Med. 2003;29(6):933‐938. (In eng). doi:10.1007/s00134‐003‐1757‐4
Øie LR, Solheim O, Majewska P, et al. Incidence and case fatality of aneurysmal subarachnoid hemorrhage admitted to hospital between 2008 and 2014 in Norway. Acta Neurochir. 2020;162(9):2251‐2259. (In eng). doi:10.1007/s00701‐020‐04463‐x
Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta‐analysis. Lancet Neurol. 2009;8(7):635‐642. (In eng). doi:10.1016/s1474‐4422(09)70126‐7
Ingall T, Asplund K, Mähönen M, Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke. 2000;31(5):1054‐1061. (In eng). doi:10.1161/01.str.31.5.1054
Konczalla J, Platz J, Schuss P, Vatter H, Seifert V, Güresir E. Non‐aneurysmal non‐traumatic subarachnoid hemorrhage: patient characteristics, clinical outcome and prognostic factors based on a single‐center experience in 125 patients. BMC Neurol. 2014;14:140. (In eng). doi:10.1186/1471‐2377‐14‐140
Qureshi AI, Jahangir N, Qureshi MH, et al. A population‐based study of the incidence and case fatality of non‐aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2015;22(3):409‐413. (In eng). doi:10.1007/s12028‐014‐0084‐7
Schatlo B, Fung C, Stienen MN, et al. Incidence and outcome of aneurysmal subarachnoid hemorrhage: the swiss study on subarachnoid hemorrhage (swiss SOS). Stroke. 2021;52(1):344‐347. (In eng). doi:10.1161/strokeaha.120.029538
Huang H, Lai LT. Incidence and case‐fatality of aneurysmal subarachnoid hemorrhage in Australia, 2008‐2018. World Neurosurg. 2020;144:e438‐e446. (In eng). doi:10.1016/j.wneu.2020.08.186
Nobels‐Janssen E, van der Wees PJ, Verhagen WIM, Westert GP, Bartels R, Boogaarts JD. Patient‐reported outcome measures in subarachnoid hemorrhage: a systematic review. Neurology. 2019;92(23):1096‐1112. (In eng). doi:10.1212/wnl.0000000000007618
Hays RD, Morales LS. The RAND‐36 measure of health‐related quality of life. Ann Med. 2001;33(5):350‐357. (In eng). doi:10.3109/07853890109002089
Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38(3):1091‐1096. (In eng). doi:10.1161/01.STR.0000258355.23810.c6
Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their use. J Neurotrauma. 1998;15(8):573‐585. (In eng). doi:10.1089/neu.1998.15.573
van Lieshout JH, Bruland I, Fischer I, et al. Increased mortality of patients with aneurysmatic subarachnoid hemorrhage caused by prolonged transport time to a high‐volume neurosurgical unit. Am J Emerg Med. 2017;35(1):45‐50. (In eng). doi:10.1016/j.ajem.2016.09.067
Sorteberg A, Bredmose PP, Hansen AE, Sorteberg W. The path from ictus to neurosurgery: chronology and transport logistics of patients with aneurysmal subarachnoid haemorrhage in the south‐eastern Norway health region. Acta Neurochir. 2019;161(8):1497‐1506. (In eng). doi:10.1007/s00701‐019‐03971‐9
Statistical database for causes of death. Swedish National Board of Health and Welfare. https://sdb.socialstyrelsen.se/if_dor/resultat.aspx Accessed July 18, 2023.